Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-23

FDA Approved: FENOFIBRATE — Supplemental Application (AvKARE)

View source ↗

Summary

The FDA has approved a supplemental application for AvKARE's fenofibrate product, signaling an update to the approved formulation/manufacturer details for the g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)

Snippet

SUPPL AP for FENOFIBRATE (FENOFIBRATE)